⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10864050 | 0.97 | — | — | |
| SCHEMBL17784059 | 0.85 | — | — | |
| SCHEMBL7484712 | 0.75 | ALDH1A1 (0.33) | — | |
| SCHEMBL27832293 | 0.75 | — | — | |
| SCHEMBL9353316 | 0.73 | ALDH1A1 (0.30) | — | |
| SCHEMBL6326338 | 0.67 | — | — | |
| SCHEMBL18650123 | 0.67 | — | — | |
| SCHEMBL325976 | 0.67 | — | — | |
| SCHEMBL18725208 | 0.65 | — | — | |
| SCHEMBL12125457 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230201361-A1 | TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES | ONCOLMMUNIN INC (US) | 2023-06-29 | — | — | US | claimed |
| EP-4087587-A1 | TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES | ONCOIMMUNIN, INC. (US) | 2022-11-16 | — | — | EP | claimed |
| JP-2002534434-A | — | — | 2002-10-15 | — | — | JP | claimed |
| EP-1140966-A1 | ACID STABLE BACKBONE MODIFIED END-BLOCKED NUCLEIC ACIDS AND THERAPEUTIC USES THEREOF | Oligos Etc. Inc. (US) | 2001-10-10 | — | — | EP | claimed |
| WO-2000040592-A1 | ACID STABLE BACKBONE MODIFIED END-BLOCKED NUCLEIC ACIDS AND THERAPEUTIC USES THEREOF | OLIGOS ETC. INC. (US) | 2000-07-13 | — | — | WO | claimed |
| US-20230201361-A1 | TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES | ONCOLMMUNIN INC (US) | 2023-06-29 | — | — | US | disclosed |
| US-20230065782-A1 | TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES | ONCOIMMUNIN INC (US) | 2023-03-02 | — | — | US | disclosed |
| EP-4087587-A1 | TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES | ONCOIMMUNIN, INC. (US) | 2022-11-16 | — | — | EP | disclosed |
| EP-3044228-B1 | HIGHLY EFFICIENT SYNTHESIS OF LONG RNA USING REVERSE DIRECTION APPROACH | CHEMGENES CORP (US) | 2021-04-07 | — | — | EP | disclosed |
| US-20190298824-A1 | ALBUMIN-BINDING IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERV (US) | 2019-10-03 | — | — | US | disclosed |
| US-10167308-B2 | Highly efficient synthesis of long RNA using reverse direction approach | CHEMGENES CORPORATION (US) | 2019-01-01 | — | — | US | disclosed |
| WO-2017192874-A1 | ALBUMIN-BINDING IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2017-11-09 | — | — | WO | disclosed |
| US-20060040879-A1 | Chloroquine coupled nucleic acids and methods for their synthesis | KOSAK KENNETH M | 2006-02-23 | — | — | US | disclosed |
| EP-1202998-B1 | SYNTHESIS OF STABLE QUINONE AND PHOTOREACTIVE KETONE PHOSPHORAMIDITE REAGENTS FOR SOLID PHASE SYNTHESIS OF PHOTOREACTIVE-OLIGOMER CONJUGATES | EXIQON AS (DK) | 2003-11-19 | — | — | EP | disclosed |
| US-6531591-B1 | N,N-diisopropyl-O-(2-cyanoethyl)-O'-((anthraquinon-2 -yl)carbonylaminopropyl) phosphoramidite for example; oligonucleotides terminating in a photoreactive moiety | EXIQON A/S (DK) | 2003-03-11 | — | — | US | disclosed |
| US-20030045490-A1 | Therapeutic antisense phosphodiesterase inhibitors | OLIGOS ETC. INC. | 2003-03-06 | — | — | US | disclosed |
| EP-1202998-A1 | SYNTHESIS OF STABLE QUINONE AND PHOTOREACTIVE KETONE PHOSPHORAMIDITE REAGENTS FOR SOLID PHASE SYNTHESIS OF PHOTOREACTIVE-OLIGOMER CONJUGATES | Exiqon A/S (DK) | 2002-05-08 | — | — | EP | disclosed |
| EP-1141278-A2 | THERAPEUTIC PHOSPHODIESTERASE INHIBITORS | Oligos Etc. Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2001004129-A1 | SYNTHESIS OF STABLE QUINONE AND PHOTOREACTIVE KETONE PHOSPHORAMIDITE REAGENTS FOR SOLID PHASE SYNTHESIS OF PHOTOREACTIVE-OLIGOMER CONJUGATES | EXIQON A/S (DK) | 2001-01-18 | — | — | WO | disclosed |
| WO-2000040714-A2 | THERAPEUTIC PHOSPHODIESTERASE INHIBITORS | OLIGOS ETC. INC. (US) | 2000-07-13 | — | — | WO | disclosed |